Popis EZ-a
Popis EZ-a
Nested Applications
Popis EZ-a
The EC inventory published below is a copy as received from the JRC in 2008 on the founding of ECHA. It is comprised of the following lists:
- EINECS (European INventory of Existing Commercial chemical Substances) as published in O.J. C 146A, 15.6.1990. EINECS is an inventory of substances that were deemed to be on the European Community market between 1 January 1971 and 18 September 1981. EINECS was drawn up by the European Commission in the application of Article 13 of Directive 67/548/EEC, as amended by Directive 79/831/EEC, and in accordance with the detailed provisions of Commission Decision 81/437/EEC. Substances listed in EINECS are considered phase-in substances under the REACH Regulation.
- ELINCS (European LIst of Notified Chemical Substances) in support of Directive 92/32/EEC, the 7th amendment to Directive 67/548/EEC. ELINCS lists those substances which were notified under Directive 67/548/EEC, the Dangerous Substances Directive Notification of New Substances (NONS) that became commercially available after 18 September 1981.
- NLP (No-Longer Polymers). The definition of polymers was changed in April 1992 by Council Directive 92/32/EEC amending Directive 67/548/EEC, with the result that substances previously considered to be polymers were no longer excluded from regulation. Thus the No-longer Polymers (NLP) list was drawn up, consisting of such substances that were commercially available between 18 September 1981 and 31 October 1993.
Database contains 106212 unique substances/entries.
Filter the list
The List does not contain any Substances.
444-810-6
|
-
|
CP-163,625-BV
|
Details | ||
LC-OLIGOMER
|
454-660-3
|
-
|
LC-OLIGOMER
|
Details | |
480-680-7
|
-
|
Details | |||
474-260-2
|
-
|
Details | |||
430-150-6
|
-
|
CENTIFOLETHER
|
Details | ||
443-930-6
|
-
|
HEXAFUR-LAC
|
Details | ||
429-980-1
|
-
|
KOUMALACTONE
|
Details | ||
436-150-2
|
-
|
POSACONAZOLE WB; SCH 56592-WB
|
Details | ||
450-320-3
|
-
|
DIHYDROFARNESOL
|
Details | ||
427-550-8
|
-
|
(4-6) PEPTIDE
|
Details | ||